JP2022552940A5 - - Google Patents
Info
- Publication number
- JP2022552940A5 JP2022552940A5 JP2022517729A JP2022517729A JP2022552940A5 JP 2022552940 A5 JP2022552940 A5 JP 2022552940A5 JP 2022517729 A JP2022517729 A JP 2022517729A JP 2022517729 A JP2022517729 A JP 2022517729A JP 2022552940 A5 JP2022552940 A5 JP 2022552940A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- small molecule
- thrombocytopenia
- modification
- molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910891508.8 | 2019-09-20 | ||
| CN201910891508 | 2019-09-20 | ||
| PCT/CN2020/116227 WO2021052470A1 (zh) | 2019-09-20 | 2020-09-18 | 用于治疗血小板减少症的核酸分子及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022552940A JP2022552940A (ja) | 2022-12-21 |
| JP2022552940A5 true JP2022552940A5 (cg-RX-API-DMAC10.html) | 2023-09-25 |
Family
ID=74883124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022517729A Pending JP2022552940A (ja) | 2019-09-20 | 2020-09-18 | 血小板減少症を治療するための核酸分子及びその応用 |
Country Status (12)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111849968A (zh) | 2019-04-30 | 2020-10-30 | 中美瑞康核酸技术(南通)研究院有限公司 | 寡核苷酸分子及其在急性间歇性卟啉症治疗中的应用 |
| AU2024255186A1 (en) * | 2023-04-12 | 2025-10-30 | Alnylam Pharmaceuticals, Inc. | Formulations for oligonucleotide delivery |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6270989B1 (en) * | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
| GB2285446B (en) * | 1994-01-03 | 1999-07-28 | Genentech Inc | Thrombopoietin |
| JP5362350B2 (ja) * | 2005-04-15 | 2013-12-11 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 小分子活性化ｒｎａ分子及び使用方法 |
| CA2629664A1 (en) * | 2005-11-17 | 2007-08-02 | Board Of Regents, The University Of Texas System | Modulation of gene expression by oligomers targeted to chromosomal dna |
| KR20220038506A (ko) | 2009-06-10 | 2022-03-28 | 알닐람 파마슈티칼스 인코포레이티드 | 향상된 지질 조성물 |
| GB201010557D0 (en) * | 2010-06-23 | 2010-08-11 | Mina Therapeutics Ltd | RNA molecules and uses thereof |
| WO2012175958A1 (en) * | 2011-06-21 | 2012-12-27 | Mina Therapeutics Limited | Albumin production and cell proliferation |
| CN106032532A (zh) * | 2015-03-17 | 2016-10-19 | 中国医学科学院北京协和医院 | 一种小激活rna及其制备方法和应用 |
| CN108291228A (zh) * | 2015-04-22 | 2018-07-17 | 米纳治疗有限公司 | C/EBPαSARNA组合物和使用方法 |
| EP3286318A2 (en) * | 2015-04-22 | 2018-02-28 | Mina Therapeutics Limited | Sarna compositions and methods of use |
| WO2017106283A1 (en) * | 2015-12-14 | 2017-06-22 | Cold Spring Harbor Laboratory | Compositions and methods for treatment of liver diseases |
| CN106480028B (zh) * | 2016-10-12 | 2019-04-05 | 上海市第七人民医院 | TPO基因的saRNA分子及其应用 |
-
2020
- 2020-09-18 CA CA3148158A patent/CA3148158A1/en active Pending
- 2020-09-18 BR BR112022005028A patent/BR112022005028A2/pt not_active Application Discontinuation
- 2020-09-18 CN CN202080065027.2A patent/CN114585738A/zh active Pending
- 2020-09-18 JP JP2022517729A patent/JP2022552940A/ja active Pending
- 2020-09-18 US US17/753,927 patent/US20230212565A1/en not_active Abandoned
- 2020-09-18 PE PE2022000448A patent/PE20220604A1/es unknown
- 2020-09-18 EP EP20866111.6A patent/EP4036232A4/en not_active Withdrawn
- 2020-09-18 WO PCT/CN2020/116227 patent/WO2021052470A1/zh not_active Ceased
- 2020-09-18 KR KR1020227008451A patent/KR20220070206A/ko not_active Withdrawn
- 2020-09-18 AU AU2020349991A patent/AU2020349991A1/en not_active Abandoned
- 2020-09-21 TW TW109132616A patent/TW202126808A/zh unknown
-
2022
- 2022-04-18 CO CONC2022/0004857A patent/CO2022004857A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2204913T3 (es) | Metodo para formacion de oligonucleotidos. | |
| Lu et al. | Multifunctional DNA origami nanoplatforms for drug delivery | |
| JP2007503474A5 (cg-RX-API-DMAC10.html) | ||
| JP2005517438A5 (cg-RX-API-DMAC10.html) | ||
| JP2006502694A5 (cg-RX-API-DMAC10.html) | ||
| JP2014527401A5 (cg-RX-API-DMAC10.html) | ||
| JP2005517433A5 (cg-RX-API-DMAC10.html) | ||
| JP2005517436A5 (cg-RX-API-DMAC10.html) | ||
| JP2005517432A5 (cg-RX-API-DMAC10.html) | ||
| JP2007529224A5 (cg-RX-API-DMAC10.html) | ||
| SK6042002A3 (en) | High order nucleic acid based structures | |
| WO2025157271A1 (zh) | 一种抑制f11基因表达的核酸分子 | |
| JP2023521042A (ja) | 操作されたオリゴヌクレオチドを使用する標的化された阻害 | |
| WO2015099122A1 (ja) | 遺伝子発現制御のための人工ミミックｍｉＲＮＡおよびその用途 | |
| CN112996913A (zh) | 寡聚核酸分子及其应用 | |
| KR100929699B1 (ko) | 다수 표적 유전자들을 제어하는 간섭 유도 ｒｎａ들 및그들의 제조방법 | |
| CN113249380A (zh) | 靶向covid-19新冠病毒的反义寡核苷酸、natac嵌合分子及其应用 | |
| JP2022536945A5 (cg-RX-API-DMAC10.html) | ||
| CN104919059B (zh) | 旋转性隔离的翻译元件 | |
| ES2421314T3 (es) | Constructos de ADN para la inhibición específica de la expresión génica mediante interferencia de ARN | |
| TWI606058B (zh) | Nucleic acid complex and nucleic acid polysaccharide complex | |
| CN102876658A (zh) | 一种大规模合成长链核酸分子的方法 | |
| CN118460655B (zh) | 抑制FXI基因表达的siRNA的制备方法 | |
| CN118460649B (zh) | 一种Vutrisiran的制备方法 | |
| EP4036232A1 (en) | Nucleic acid molecule for treating immune thrombocytopenia and application thereof |